Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management
LifeSciVC
JUNE 12, 2025
This ability to activate pathways could be possible for almost all proteins, however the biggest differentiation was to consider areas that were hard to drug – transcription factors, ion channels, intracellular proteins, etc. Is it more important to have a clinical meaningful drug candidate OR convenience?
Let's personalize your content